United Therapeutics Corp. (UTHR) News Nov 20, 2014, 5:33

New Post Public Reply Private Reply Replies (0) Message Board

Nov 21, 2014 at 1:48 AM

United Therapeutics Corp. (UTHR) News Nov 20, 2014, 5:33 p.m.
MarketWatch News on UTHR
Despite bullish backdrop, technical tests are in play 11:26 a.m. Sept. 9, 2014 - Michael Ashbaugh
Despite bullish backdrop, technical tests are in play 11:07 a.m. Sept. 9, 2014 - Michael Ashbaugh
Charting the technical (and bullish) cross currents 12:51 p.m. Feb. 21, 2014 - Michael Ashbaugh
CalAmp drops, ImmunoCellular rises after hours 6:07 p.m. Dec. 23, 2013 - Wallace Witkowski
Sell in November? No 10:52 a.m. Oct. 31, 2013 - Michael Ashbaugh
Charting the Nasdaq’s 12-year breakout 11:56 a.m. April 30, 2013 - Michael Ashbaugh
Charting the Nasdaq’s 12-year breakout 11:34 a.m. April 30, 2013 - Michael Ashbaugh
United Therapeutics: FDA again rejects drug 6:56 a.m. March 25, 2013 - MarketWatch.com
Look for bargains in health care, tech, energy, housing and airlines: Sabrient's Brown 4:46 p.m. Nov. 21, 2012 - blogs.marketwatch.com
Wednesday’s biggest movers: Facebook, Yelp rally 6:29 p.m. Oct. 24, 2012 - Sue Chang
FDA declines to OK United Therapeutics product 6:53 a.m. Oct. 24, 2012 - MarketWatch.com
Charting the longer-term market backdrop 11:30 a.m. Sept. 25, 2012 - Michael Ashbaugh
Charting the longer-term market backdrop 10:53 a.m. Sept. 25, 2012 - Michael Ashbaugh
S&P, Nasdaq retest major support 10:09 a.m. July 11, 2012 - Michael Ashbaugh
6 charts for the week 12:54 p.m. June 25, 2012 - The Trading Deck
13 stocks for 2012 5:57 p.m. Jan. 5, 2012 - blogs.marketwatch.com
Wednesday’s biggest gaining and declining stocks 3:29 p.m. Aug. 24, 2011 - Kate Gibson
Biogen, Acura lead drug stocks north 2:54 p.m. June 20, 2011 - Val Brickates Kennedy
Monday’s biggest gaining and declining stocks 5:50 p.m. June 6, 2011 - Kate Gibson
Utd Therapeutics hypertension drug hits trial goal 11:32 a.m. June 6, 2011 - MarketWatch.com

Other News on UTHR
The 3 Best ETFs for Mid-Cap Growth 5:50 a.m. Nov. 17, 2014 - InvestorPlace.com
United Therapeutics Sells Off On Good News - Why I Bought That Dip 3:52 p.m. Oct. 30, 2014 - Seeking Alpha
United Therapeutics Falls on Q3 Loss, Revenues Miss - Analyst Blog 12:02 p.m. Oct. 29, 2014 - Zacks.com
United Therapeutics' (UTHR) CEO Martine Rothblatt on Q3 2014 Results - Earnings Call Transcript 6:10 p.m. Oct. 28, 2014 - Seeking Alpha
United Therapeutics ups revenues 9% in Q3 10:53 a.m. Oct. 28, 2014 - Seeking Alpha
Worst Performing Industries For October 28, 2014 10:13 a.m. Oct. 28, 2014 - benzinga.com
Weak On High Volume: United Therapeutics (UTHR) 10:04 a.m. Oct. 28, 2014 - TheStreet.com
United Therapeutics (UTHR) Q3 2014 Results - Earnings Call Webcast 8:55 a.m. Oct. 28, 2014 - Seeking Alpha
10-Q: UNITED THERAPEUTICS CORP 6:06 a.m. Oct. 28, 2014 - Edgar Online - (EDG = 10Q, 10K)
United Therapeutics Corporation (UTHR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Oct. 27, 2014 - Zacks.com
Japan Gives A Hug To The Cell Therapy Industry: R. Lee Buckler 8:21 a.m. Oct. 24, 2014 - Seeking Alpha
Biotechs Show Fed Chief's Not Much Of A Stock Analyst 4:01 p.m. Oct. 22, 2014 - Investors Business Daily
Avanir (AVNR) Presents Detailed Phase II Data on AVP-923 - Analyst Blog 5:30 p.m. Oct. 14, 2014 - Zacks.com
J&J Beats Q3 Earnings on Strong Drug Sales, Ups View - Analyst Blog 11:27 a.m. Oct. 14, 2014 - Zacks.com
Weekly CFO Sells Highlight: United Therapeutics Corp, Williams Companies Inc, Facebook Inc. 10:58 a.m. Oct. 12, 2014 - GuruFocus.com
A Look At Arena's Other Drug 4:37 p.m. Oct. 3, 2014 - Seeking Alpha
Biotech Stocks Rebound On Strong Earnings, New Drugs 5:32 p.m. Sept. 29, 2014 - Investors Business Daily
Can the Uptrend Continue for United Therapeutics (UTHR)? - Tale of the Tape 10:34 a.m. Sept. 24, 2014 - Zacks.com
Moving Average Crossover Alert: United Therapeutics (UTHR) - Tale of the Tape 9:09 a.m. Sept. 23, 2014 - Zacks.com
United Therapeutics Points To Pluristem's PLX-PAD As Its Most Transformative Product 9:49 a.m. Sept. 19, 2014 - Seeking Alpha

Press Releases on UTHR
Professor Katherine J. Klein Joins The United Therapeutics Corporation Board Of Directors 6:00 a.m. Nov. 13, 2014 - PR Newswire - PRF
Clinical Trial Results, Product Approval Letter, Financial Results, and Upcoming Event - Research Reports on Receptos, Wright, United Therapeutics, Abbott and CareFusion 7:40 a.m. Oct. 31, 2014 - PR Newswire - PRF
Mid-Atlantic Claims $8.5 Billion Slice of $62 Billion North American Life Science Capital/MRO Investment Pie, an Industrial Info News Alert 5:15 a.m. Oct. 31, 2014 - Marketwired
Market Movers - Biotech Stocks -- NewLink Genetics, Biogen Idec, United Therapeutics, Dynavax Technologies, and Amarin 7:40 a.m. Oct. 29, 2014 - PR Newswire - PRF
United Therapeutics Corporation Reports Third Quarter 2014 Financial Results 5:00 a.m. Oct. 28, 2014 - PR Newswire - PRF
United Therapeutics Corporation To Announce Third Quarter 2014 Financial Results Before Market Open On Tuesday, October 28, 2014 5:00 a.m. Oct. 21, 2014 - PR Newswire - PRF
Creator of GeoStar and Sirius Radio, Martine Rothblatt to speak at the Church of Perpetual Life 3:06 p.m. Oct. 20, 2014 - PR Newswire - PRF
Upcoming Events, New Facilities, Technical Updates, and Pilot Programs - Research Reports on Aetna, United Therapeutics, Quest Diagnostics, Cummins and Danaher 7:30 a.m. Oct. 8, 2014 - PR Newswire - PRF
Regulatory Approvals, Senior Notes Redemption, and Technical Updates - Research Reports on Tekmira, Regeneron, Valeant, Teva and United Therapeutics 8:20 a.m. Sept. 25, 2014 - PR Newswire - PRF
Axsome Therapeutics Announces Appointments to Its Board of Directors 6:31 a.m. Sept. 17, 2014 - GlobeNewswire
United Therapeutics Points to Pluristem's PLX-PAD as its Most Transformative Product 5:50 a.m. Sept. 17, 2014 - ACCESSWIRE
Pluristem Pursues Development Strategy in Japan Where New Law Accelerates Path to Market 2:01 a.m. Sept. 16, 2014 - GlobeNewswire
Study Results, New Collaboration, Drug Designation, Technical Update, and Completion of Transaction - Research Reports on Gilead, AbbVie, Pfizer, United Therapeutics and Brookdale 8:10 a.m. Sept. 12, 2014 - PR Newswire - PRF
United Therapeutics Advances to Second Cohort in Phase I Trial of Pluristem's PLX-PAD Cells for Treatment of Pulmonary Arterial Hypertension 2:01 a.m. Sept. 8, 2014 - GlobeNewswire
Favourable Rulings, Upcoming Conferences, Clinical Study Results, Drug Availability, and Tender Offers - Research Reports on United Therapeutics, Illumina, AstraZeneca, Eli Lilly and Abbott 8:20 a.m. Sept. 3, 2014 - PR Newswire - PRF
Critical Alerts For bluebird bio Inc., United Therapeutics Corporation, Mattel Inc, Ulta Salon Cosmetics & Fragrance Inc. and Applied Materials Inc. Released By InvestorsObserver 8:31 a.m. Sept. 2, 2014 - PR Newswire - PRF
District Court Decision Received In Remodulin Patent Case 11:49 a.m. Aug. 29, 2014 - PR Newswire - PRF
Spinal Stenosis Global Clinical Trials Review, H2, 2014 6:20 p.m. Aug. 11, 2014 - PR Newswire - PRF
United Therapeutics Corporation Reports Second Quarter 2014 Financial Results 5:00 a.m. July 29, 2014 - PR Newswire - PRF
United Therapeutics Corporation To Announce Second Quarter 2014 Financial Results Before Market Open On Tuesday, July 29, 2014 5:00 a.m. July 22, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Health Hit by FTC Claims and Class Action

Hims Faces Harsh Lessons With FTC Lawsuit There's trouble brewing in the world of telehealth, and Hims & Hers Health (NYSE: HIMS) is right at the eye of the storm. They've gone from a darling of digital health to a pariah faster than you can say 'data breach.' On July 29, 2026, they took a hit so hard you’d think the company stepped into the ring with a heavyweight...

Celebree Elevates Early Ed with New Certification Push

A New Standard in Early Childhood Education In the cutthroat world of childcare and early education, just meeting the state standards ain't cutting it anymore. Celebree School, known for its infant, toddler, and preschool programs, is shaking things up with its 'Celebree Certified' initiative, setting a brand-new benchmark for teacher readiness that's far beyond the usual...

PBC 2026 Forum: Philanthropic Titans Collide in HK

A Decade of Philanthropic Discourse The winds of change blew through Hong Kong’s West Kowloon Cultural District today, marking the tenth anniversary of the PBC 2026 forum—an event that’s got everyone from government bigwigs to sports icons chatting. Convened by The Hong Kong Jockey Club Charities Trust alongside the Institute of Philanthropy, this two-day journey is...

WaFd and EverBank $3.9B Deal Spurs Big Bank Shift

Remember the good old days when banking was just about collecting interest? Now it's all about combining forces to bolster strength, and that's just what we're seeing with WaFd, Inc. (NASDAQ: WAFD) and EverBank Financial Corp flipping the script and shaking hands on a $3.9 billion reverse merger. Strategic Vision: A New Chapter They're calling it a 'strategic...

Lyon Biennale 2026: Art, Dreams, and Lyon's Magic

Unveiling the Art Spectacle in Lyon Alright, buckle up folks, because the 18th Lyon Biennale – Contemporary Art is about to take the stage in grand fashion. Starting on the 19th of September, this art fiesta is not just any exhibit; it's an eleven-venue citywide takeover that runs until the 13th of December, and it is poised to shake up the art scene like a good splash...

MADD, Uber Rally at Capital Invitational for Safe Choices

Driving Change at the Capital Invitational Let's talk about a powerhouse collaboration aiming to do more than just thrill basketball fans. We're looking at MADD Sports, Uber, and the Capital Invitational joining forces at The St. James in Springfield, Virginia, on December 10, 2026. This is not your average sporting event; it's a gathering with a bigger purpose. The...

Michigan Roof Inspections: Seasonal Insights That Count

Weather's Wrath and the Michigan Roof Here's the deal: Michigan doesn't mess around when it comes to weather. We're talking harsh winters with piles of snow, followed by muggy summers that toss storms like they're confetti. Keeping that roof in top shape isn't just some luxury; it’s a downright necessity. Gut-punch reality? Many ignore it until it's too late. That's...

DNOW Faces Class Action: Proxy Missteps Under Fire

DNOW's Rough Patch: Investors, Beware Here's a tangled mess for you: DNOW Inc., a name that should've been cruising post-merger, now finds itself smack in the middle of a class action lawsuit. Blame it on some botched acquisition moves with MRC Global Inc. The suits claim DNOW's management may have played fast and loose with the truth during their big merger spiel. When...

Early Orders Key for Custom Kids' Gifts This Season

Unwrap the Secret to Perfect Holiday Presents When it comes to giving the little ones something special for the holidays, the trick lies in timing. Not your run-of-the-mill timing, mind you—I'm talking about understanding how handcrafted, personalized toys can make or break the season. If you've ever scrambled for a last-minute gift, you know how that shaky feeling sets...

India's First Upright Proton Therapy System Unveiled

A Leap Forward in Cancer Care: Proton Therapy Revolution Dang, just when you think you've heard it all in cancer treatment, Fortis Healthcare drops a bombshell: India’s first upright proton therapy system. Boom! This isn't your run-of-the-mill radiation treatment we're talking about here. This is the futuristic flair of the MEVION S250-FIT™, featuring upright...